The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines

Many of the vaccines under development for COVID-19 involve the use of viral vectors. The Brighton Collaboration Benefit-Risk Assessment of Vaccines by Technology (BRAVATO, formerly the Viral Vector Vaccine Safety Working Group, V3SWG) working group has prepared a standardized template to describe t...

Descripción completa

Detalles Bibliográficos
Autores principales: Condit, Richard C, Kim, Denny, Robertson, James S., Excler, Jean-Louis, Gurwith, Marc, Monath, Thomas P., Pavlakis, George, Fast, Patricia E., Smith, Jonathan, Smith, Emily R., Chen, Robert T., Kochhar, Sonali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474958/
https://www.ncbi.nlm.nih.gov/pubmed/32907759
http://dx.doi.org/10.1016/j.vaccine.2020.08.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474958/
https://www.ncbi.nlm.nih.gov/pubmed/32907759
http://dx.doi.org/10.1016/j.vaccine.2020.08.009

Ejemplares similares